about
Not only for melanoma. Subcutaneous pseudoprogression in lung squamous-cell carcinoma treated with nivolumab: A case report.ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism.Clinical Impact of Hybrid Capture-Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer.Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases.Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data.Durable brain response with pulse-dose crizotinib and ceritinib in ALK-positive non-small cell lung cancer compared with brain radiotherapy.Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience.RET Fusion Lung Carcinoma: Response to Therapy and Clinical Features in a Case Series of 14 Patients.Intensity-modulated radiotherapy is a safe and effective treatment for localized malignant pleural mesotheliomaBRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point InhibitorsThe Clinical Impact of Comprehensive Genomic Testing of Circulating Cell-Free DNA in Advanced Lung CancerRare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi)Clinical activity of brigatinib in ROS1-rearranged non-small cell lung cancer
P50
Q37619551-B124E598-D185-40DE-B115-7CC65C7A3E72Q39027616-638A5D62-FB69-4A32-A74C-06FBAAE4B686Q39171705-9298A051-64A2-4F43-91A3-FFA95655AFE7Q39619776-3C215B6E-C51E-4962-ABA2-911C1D1DC8EEQ47287282-1D1EA30F-BC77-47E9-8766-C8E2434AF8B3Q49136789-299F90A6-C7CB-43EC-A35F-9EC5B867F925Q49898050-490318EC-8DEF-4A3E-B937-4C1335992B7EQ54154558-0A504413-C546-4A83-B156-F18C93045D12Q57153508-9BDF6B5E-A2F7-4E50-96DD-88146B8DCD05Q88557903-A30E8ABF-4720-4B8A-9D14-643274E54599Q91019530-68EC67C4-0911-4779-808A-12BEE05D091DQ91879958-BF649177-CDB6-42BA-8F5B-9D78500F278BQ95936998-C993EF4B-C26D-47CB-8311-FAB9C9D910EF
P50
description
researcher ORCID ID = 0000-0001-6971-3576
@en
wetenschapper
@nl
name
Elizabeth Dudnik
@ast
Elizabeth Dudnik
@en
Elizabeth Dudnik
@es
Elizabeth Dudnik
@nl
type
label
Elizabeth Dudnik
@ast
Elizabeth Dudnik
@en
Elizabeth Dudnik
@es
Elizabeth Dudnik
@nl
prefLabel
Elizabeth Dudnik
@ast
Elizabeth Dudnik
@en
Elizabeth Dudnik
@es
Elizabeth Dudnik
@nl
P1153
57000134800
P21
P31
P496
0000-0001-6971-3576